Download | < Back |
23 Dec 2016 | |
Sun Pharmaceutical Industries Ltd has informed BSE that one of the wholly owned subsidiaries of the Company has acquired<BR>13,000,000 Series B Preferred Stock of scPharmaceuticals Inc. (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment. scPharmaceuticals Inc., is a United States pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. | |
View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |